Wendys Co
XBER:TQK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Wendys Co
XBER:TQK
|
US |
|
B
|
Benitec Biopharma Inc
XBER:BJ9
|
US |
|
B
|
Brightview Holdings Inc
NYSE:BV
|
US |
Wall St Price Targets
TQK Price Targets Summary
Wendys Co
According to Wall Street analysts, the average 1-year price target for
TQK is 7.56 EUR with a low forecast of 4.749 EUR and a high forecast of 12.836 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TQK's stock price target?
Price Target
7.56
EUR
According to Wall Street analysts, the average 1-year price target for
TQK is 7.56 EUR with a low forecast of 4.749 EUR and a high forecast of 12.836 EUR.
What is the Revenue forecast for Wendys Co?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 5 years is 3%.
What is the Gross Profit forecast for Wendys Co?
Projected CAGR
-26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 5 years is -26%.
What is the Operating Income forecast for Wendys Co?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 5 years is 2%.
What is the Pre-Tax Income forecast for Wendys Co?
Projected CAGR
-6%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -6%.
What is the Net Income forecast for Wendys Co?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 5 years is 3%.